10THERMA sales have hit a new milestone in Taiwan.

Tentech Inc., a medical device manufacturer, announced on Tuesday that 10THERMA had sold 120 units in the first half of 2024.

Last year, Tentech Inc. participated in the Taiwan Dermatology Association (TDA) and introduced 10THERMA for the first time in Taiwan. Currently, Tentech Inc. is actively conducting marketing campaigns in Taiwan. As a result, Tentech Inc. has achieved great success, having already exported over 120 units of 10THERMA in Taiwan.

10THERMA is a 6.78MHz monopolar RF treatment device with a maximum output of 400W. It delivers RF energy to the dermis, generating heat through the skin's electrical resistance. The 5㎠ face tip of 10THERMA is wider than those of other RF devices, allowing for 25% more energy coverage per shot. 10THERMA features an S.T.C. (Smart Temperature Cooling) system, which emits a total of seven cooling pulses during a shot. Additionally, 10THERMA is equipped with impedance matching technology that helps adjust precise targeted energy for individuals.

This effectiveness and safety have led to certifications not only from Ministry of Food and Drug Safety of the Republic of Korea (MFDS) but also from the U.S. Food and Drug Administration (the U.S. FDA) ,the Taiwan Food and Drug Administration (TFDA) and so on. 10THERMA is expected to sell a total of 250 units in Taiwan by 2024.

Mr. Han, CEO of Tentech Inc., state, "By exporting 250 units of 10THERMA to Taiwan this year, we aim to demonstrate the exceptional technology and effectiveness of 10THERMA worldwide.”and he added “We will continue to expand our global market shares through innovative products.”

Meanwhile, Tentech Inc. has entered exclusive contracts with the global distributors in various countries including the U.S., Hong Kong, Singapore, Malaysia, Indonesia, Vietnam, Brazil, Thailand, the Philippines, Russia, Uzbekistan, Kazakhstan, and the United Arab Emirates (UAE), expanding its presence in the global market.